Innovations in Immune Profiling for Clinical Research
 

CAP Today: Innovations in Immune Profiling for Clinical Research

In this webinar we heard leading experts discuss how they are leveraging flow cytometry to expand and improve the immune profiles of every precious sample in clinical research trials.

Presenters:

CAP TODAY

April 25, 2022 | On Demand

View details

Caroline Roe

Cutting Edge Cytometry and Clinical Trials: ​A Case Study

Presenter: Caroline Roe, MLI
Managing Director 

Cancer & Immunology Core
Vanderbilt University


Roe shares her approach to high-parameter immune monitoring panel design, as well as the planning and execution of clinical correlative studies. She discusses the utility of patient-specific analysis tools for high-dimensional cytometry data and inferring biological significance from research assays.

Sasidhar Vemula

Method Validation Studies Ssing the Maxpar® Direct™ Immune Profiling Assay™

Presenter: Sasidhar Vemula, PhD
Lead Scientist
Translational Biomarker
Labcorp Drug Development
Vanderbilt University


Vemula details the validation process for two Maxpar panels offered by Labcorp: the Maxpar Direct Immune Profiling Assay and the Maxpar Basic Human T Cell Immuno-Oncology Panel Set.

Vinicius Motta

Efficient, High-Content Immune Profiling with CyTOF® XT and ​Maxpar Direct Immune Profiling Assay

Presenter: Vinicius Motta, PhD
Field Applications Specialist
Standard BioTools


Motta describes how fully automated flow cytometry with CyTOF XT combined with the deep immune profiling provided by the Maxpar Direct Immune Profiling Assay standardizes and simplifies a crucial application for clinical research.

Unless explicitly and expressly stated otherwise, all Standard BioTools products are provided for Research Use Only, not for use in diagnostic procedures. For more information see www.fluidigm.com/legal/notices.